Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT06397911 · RECRUITING
Trial details
- NCT number
- NCT06397911
- Sponsor
- Oneness Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-08
- Primary completion
- 2027-05-31
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.